Related references
Note: Only part of the references are listed.Effect of bisphenol A on reproductive processes: A review of in vitro, in vivo and epidemiological studies
Agnieszka Tomza-Marciniak et al.
JOURNAL OF APPLIED TOXICOLOGY (2018)
Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
Emily J. Faivre et al.
MOLECULAR CANCER RESEARCH (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
Philip Cornford et al.
EUROPEAN UROLOGY (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2017)
C-terminally truncated constitutively active androgen receptor variants and their biologic and clinical significance in castration-resistant prostate cancer
Anca Azoitei et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer
Bruce Montgomery et al.
CLINICAL CANCER RESEARCH (2016)
Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer
Minoru Kato et al.
CLINICAL CANCER RESEARCH (2016)
Androgen receptor aberrations in the era of abiraterone and enzalutamide
Florian Jentzmik et al.
WORLD JOURNAL OF UROLOGY (2016)
EPI-001, A Compound Active against Castration-Resistant Prostate Cancer, Targets Transactivation Unit 5 of the Androgen Receptor
Eva De Mol et al.
ACS CHEMICAL BIOLOGY (2016)
An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer
Axel S. Merseburger et al.
ADVANCES IN THERAPY (2016)
Mechanisms of Resistance in Antihormone Therapies of Advanced Prostate Cancer
P. Thelen et al.
AKTUELLE UROLOGIE (2016)
Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant Prostate Cancer
Yu Chi Yang et al.
CLINICAL CANCER RESEARCH (2016)
Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic
Yusuke Imamura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2016)
Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain
Carmen A. Banuelos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer
Emmanuel S. Antonarakis et al.
ONCOLOGIST (2016)
An imaging agent to detect androgen receptor and its active splice variants in prostate cancer
Yusuke Imamura et al.
JCI INSIGHT (2016)
Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer
Sven Perner et al.
ONCOTARGET (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer
Chengfei Liu et al.
CLINICAL CANCER RESEARCH (2014)
Selectively Targeting the DNA-binding Domain of the Androgen Receptor as a Prospective Therapy for Prostate Cancer
Kush Dalal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Irfan A. Asangani et al.
NATURE (2014)
Characterization of Niphatenones that Inhibit Androgen Receptor N-Terminal Domain
Carmen A. Banuelos et al.
PLOS ONE (2014)
An androgen receptor N-terminal domain antagonist for treating prostate cancer
Jae-Kyung Myung et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Stepwise androgen receptor dimerization
Martin E. van Royen et al.
JOURNAL OF CELL SCIENCE (2012)
Niphatenones, Glycerol Ethers from the Sponge Niphates digitalis Block Androgen Receptor Transcriptional Activity in Prostate Cancer Cells: Structure Elucidation, Synthesis, and Biological Activity
Labros G. Meimetis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
Raymond J. Andersen et al.
CANCER CELL (2010)
Characterization of the two coactivator-interacting surfaces of the androgen receptor and their relative role in transcriptional control
V Christiaens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
Share Paper
